Jones Financial Companies
BCYC

Jones Financial Companies’s Bicycle Therapeutics BCYC Stock Holding History

Jones Financial Companies’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87K Buy
700
+200
+40% +$917 ﹤0.01% 4315
2026
Q1 		$2.15K Buy
500
+250
+100% +$1.43K ﹤0.01% 4130
2025
Q4 		$1.77K Hold
250
– – ﹤0.01% 3857
2025
Q3 		$1.85K Hold
250
– – ﹤0.01% 3722
2025
Q2 		$1.81K Hold
250
– – ﹤0.01% 3488
2025
Q1 		$2.24K Buy
250
+100
+67% +$1.18K ﹤0.01% 3220
2024
Q4 		$2.1K Buy
150
+50
+50% +$1.07K ﹤0.01% 2988
2024
Q3 		$2.32K Hold
100
– – ﹤0.01% 2645
2024
Q2 		$2.02K Buy
+100
New +$2.26K ﹤0.01% 2156

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Jones Financial Companies's BCYC Position: Q2 2026 in Review

Jones Financial Companies increased its Bicycle Therapeutics (BCYC) stake by 40% in Q2 2026, buying an estimated $917 and bringing the position to 700 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #4315.

Jones Financial Companies first reported a position in BCYC in Q2 2024 and has held it in 9 quarters since. 104 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Jones Financial Companies held 700 shares of Bicycle Therapeutics worth $2.87K as of Q2 2026.
  • Jones Financial Companies bought 200 Bicycle Therapeutics shares in Q2 2026, an estimated $917.
  • Bicycle Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4315 holding.
  • Jones Financial Companies first reported a position in Bicycle Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 104 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.